SCImago Journal & Country Rank
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE)
2023, Volume 39, Number 2, Page(s) 117-132    
[ Abstract (English) ] [ Full Text (English) ] [ PDF ]
DOI: 10.5146/tjpath.2022.01582
Development of Glioblastoma from Stem Cells to a Full-Fledged Tumor
Pavel Vladimirovich NIKITIN1, Guzel Railevna MUSINA2, Valery Nikolaevich POLOZOV3, Dmitry Nikolaevich GOREIKO4, Vladimir Mikhailovich KRASNOVSKY5, Leonard WERKENBARK6, Mauric KJELIN7, Piotr Sergeevich TIMASHEV1,8,9
1Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, MOSCOW, RUSSIA
2Federal Center for Brain and Neurotechnologies, MOSCOW, RUSSIA
3A.A. Bogomolets National Medical University, KYIV, UKRAINE
4Kharkiv National Medical University, KHARKIV, UKRAINE
5N.N. Blokhin Cancer Research Center, MOSCOW, RUSSIA
6University of Brussels, BRUSSELS, BELGIUM
7University of Bordeaux, BORDEAUX, FRANCE
8Chemistry Department, Lomonosov Moscow State University, MOSCOW, RUSSIA
9World-Class Research Center “Digital biodesign and personalized healthcare,” Sechenov First Moscow State Medical University, MOSCOW, RUSSIA

[ Abstract (English) ] [ PDF ]